By Monica E. Oss A pill with an ingestible digital sensor to track medication adherence. Medication implants and injectable medications for opioid addiction. New formulations for long-acting injectable medications for schizophrenia. These are just a few of the recent approvals by the Food and Drug Administration (FDA) of new digital treatment technologies (see The Emerging Digital Treatment Era) and innovative medication formulations in the complex consumer space (see Predicting The Future Of Medications-More Options & More Medication Adherence). This is a whole new wave of treatment options available to consumers. For executives of provider organizations and health plans, this continual stream of treatment innovations…
Content Restricted

This article is reserved for members with an active membership. Please register for a Free Membership to view this resource.

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!